» Articles » PMID: 35265728

Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms

Abstract

Background: We aimed to describe the clinical presentation of individuals presenting with prolonged recovery from coronavirus disease 2019 (COVID-19), known as long COVID.

Methods: This was an analysis within a multicenter, prospective cohort study of individuals with a confirmed diagnosis of COVID-19 and persistent symptoms >4 weeks from onset of acute symptoms. We performed a multiple correspondence analysis (MCA) on the most common self-reported symptoms and hierarchical clustering on the results of the MCA to identify symptom clusters.

Results: Two hundred thirty-three individuals were included in the analysis; the median age of the cohort was 43 (interquartile range [IQR], 36-54) years, 74% were women, and 77.3% reported a mild initial illness. MCA and hierarchical clustering revealed 3 clusters. Cluster 1 had predominantly pain symptoms with a higher proportion of joint pain, myalgia, and headache; cluster 2 had a preponderance of cardiovascular symptoms with prominent chest pain, shortness of breath, and palpitations; and cluster 3 had significantly fewer symptoms than the other clusters (2 [IQR, 2-3] symptoms per individual in cluster 3 vs 6 [IQR, 5-7] and 4 [IQR, 3-5] in clusters 1 and 2, respectively;  < .001). Clusters 1 and 2 had greater functional impairment, demonstrated by significantly longer work absence, higher dyspnea scores, and lower scores in SF-36 domains of general health, physical functioning, and role limitation due to physical functioning and social functioning.

Conclusions: Clusters of symptoms are evident in long COVID patients that are associated with functional impairments and may point to distinct underlying pathophysiologic mechanisms of disease.

Citing Articles

Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group.

Gottlieb M, Yu H, Chen J, Spatz E, Gentile N, Geyer R Lancet Reg Health Am. 2025; 44:101026.

PMID: 40040820 PMC: 11875141. DOI: 10.1016/j.lana.2025.101026.


Profiling the persistent and episodic nature of long COVID symptoms and the impact on quality of life and functional status: a cohort observation study.

Owen R, Ashton R, Bewick T, Copeland R, Ferraro F, Kennerley C J Glob Health. 2025; 15:04006.

PMID: 39913532 PMC: 11801655. DOI: 10.7189/jogh.15.04006.


SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypes.

Pasculli P, Antonacci M, Zingaropoli M, Dominelli F, Ciccone F, Pandolfi F Epidemiol Infect. 2025; 153:e40.

PMID: 39901510 PMC: 11869074. DOI: 10.1017/S0950268825000093.


Interventions for the management of long covid (post-covid condition): living systematic review.

Zeraatkar D, Ling M, Kirsh S, Jassal T, Shahab M, Movahed H BMJ. 2024; 387:e081318.

PMID: 39603702 PMC: 11600537. DOI: 10.1136/bmj-2024-081318.


Demographic and Geographic Characteristics Associated with the Type of Prescription and Drug Expenditure: Real World Evidence for Greece During 2015-2021.

Mavridoglou G, Polyzos N Healthcare (Basel). 2024; 12(22).

PMID: 39595509 PMC: 11593835. DOI: 10.3390/healthcare12222312.


References
1.
Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

2.
Cortes-Telles A, Lopez-Romero S, Figueroa-Hurtado E, Pou-Aguilar Y, Wong A, Milne K . Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021; 288:103644. PMC: 7910142. DOI: 10.1016/j.resp.2021.103644. View

3.
Montefusco L, Ben Nasr M, DAddio F, Loretelli C, Rossi A, Pastore I . Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021; 3(6):774-785. PMC: 9931026. DOI: 10.1038/s42255-021-00407-6. View

4.
Wong T, Weitzer D . Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina (Kaunas). 2021; 57(5). PMC: 8145228. DOI: 10.3390/medicina57050418. View

5.
Bansal R, Gubbi S, Koch C . COVID-19 and chronic fatigue syndrome: An endocrine perspective. J Clin Transl Endocrinol. 2021; 27:100284. PMC: 8641402. DOI: 10.1016/j.jcte.2021.100284. View